AaviGen
PrivateLast Round
Accelerator
Jun 4, 2025
Total Funding Raised
$18.85M
Company Overview
AaviGen operates in Healthcare & Life Sciences and is based in Heidelberg. Its latest recorded funding round was an Accelerator round in June 2025.
AaviGen is a biotechnology company that develops precision gene therapies for cardiovascular and cardiopulmonary diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AaviGen Comparables
Compare AaviGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Affinia Therapeutics | 80% | |
| Medera | 78% | |
| Medley Therapeutics, Inc. | 77% |
For institutional investors. Book with your work email.
AaviGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 4, 2025 | ||||
| Series B | Jul 26, 2023 |
For institutional investors. Book with your work email.
AaviGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| dievini Hopp BioTech holding | Series B |
| German Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2025
Received funding from German Accelerator.
- Jul 26, 2023
$19M round led by DH-LT Investments GmbH.
For institutional investors. Book with your work email.
AaviGen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AaviGen's valuation, stock price, and market status.
Is AaviGen a public or private company?
AaviGen is a private company.
What is the current stock price of AaviGen?
AaviGen is a private company, so its shares have no public market price. Caplight tracks AaviGen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AaviGen worth (valuation)?
Valuation information for AaviGen is not publicly available.
Can I buy AaviGen stock?
AaviGen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AaviGen's last funding round?
AaviGen's most recent funding round was Accelerator on June 4, 2025.
Who are the main investors in AaviGen?
Key investors in AaviGen include dievini Hopp BioTech holding.
Will AaviGen IPO soon?
No public IPO plans have been announced for AaviGen.
How can I track AaviGen secondary market activity?
Caplight tracks bids, offers, and trades in AaviGen's shares on secondary markets.